Development of terbinafine solid lipid nanoparticles as a topical delivery system

References

• PathanIBSettyCMChemical penetration enhancers for transdermal drug delivery systemsTrop J Pharm Res200982173179
   Web of Science ®Google Scholar
• ThiruganeshRUma DeviSKSolid lipid nanoparticle and nanoparticle lipid carrier for controlled drug delivery – a review of state of art and recent advancesInternational Journal of Nanoparticles2010313252
   Google Scholar
• SabadinCSBenvegnúSAFontouraMMCSagginLMFTomimoriJFischmanOOnychomycosis and tinea pedis in athletes from the State of Rio Grande Do Sul (Brazil): a cross-sectional studyMycopathologia2010171318318920878238
   PubMed Web of Science ®Google Scholar
• Krishnan-NatesanSTerbinafine: a pharmacological and clinical reviewExpert Opin Drug Deliv2009101627232733
   Google Scholar
• AlbertiIKaliaYNNaikABonnyJDGuyRHIn vivo assessment of enhanced topical delivery of terbinafine to human stratum corneumJ Control Release200171331932711295224
   PubMed Web of Science ®Google Scholar
• KaurIPKakkarSTopical delivery of antifungal agentsExpert Opin Drug Deliv20107111303132720961206
   PubMed Web of Science ®Google Scholar
• GuptaAKChowMDanielCRAlyRTreatments of tinea pedisDermatol Clin200321343146212956197
   PubMed Web of Science ®Google Scholar
• RobertMEMKaliaYNNew developments in topical antifungal therapyAm J Drug Delivery200644231247
   Google Scholar
• SegalBHWalshTJCurrent approaches to diagnosis and treatment of invasive aspergillosisAm J Respir Crit Care Med2006173770771716387806
   PubMed Web of Science ®Google Scholar
• O’BrienTPTherapy of ocular fungal infectionsOphthalmol Clin North Am19991213350
   Google Scholar
• FaergemannJZehenderHDenouelJMilleriouxLLevels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeksActa Derm Venereol19937343053097904107
   PubMed Web of Science ®Google Scholar
• FaergemannJZehenderHJonesTMaibachITerbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweatActa Derm Venereol19917143223261681649
   PubMed Web of Science ®Google Scholar
• HillSThomasRSmithSGFinlayAYAn investigation of the pharmacokinetics of topical terbinafine (Lamisil®) 1% creamBr J Dermatol199212743964001419761
   PubMed Web of Science ®Google Scholar
• Hosseini-YeganehMAndrewJMcLachlanTissue distribution of terbinafine in ratsJ Pharm Sci200190111817182811745740
   PubMed Web of Science ®Google Scholar
• Hosseini-YeganehMMcLachlanAJPhysiologically based pharmacokinetic model for terbinafine in rats and humansAntimicrob Agents Chemother20024672219222812069977
   PubMed Web of Science ®Google Scholar
• AlbertiIKaliaYNNaikAGuyRHAssessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in manPharm Res200118101472147511697475
   PubMed Web of Science ®Google Scholar
• SchAumlFer-KortingMSchoellmannCKortingHCFungicidal activity plus reservoir effect allows short treatment courses with terbinafine in tinea pedisSkin Pharmacol Physiol200821420321018509254
   PubMed Web of Science ®Google Scholar
• Zur MühlenAMehnertWDrug release and release mechanism of prednisolone loaded solid lipid nanoparticlesPharmazie1998538552555
   Web of Science ®Google Scholar
• Zur MühlenASchwarzCMehnertWSolid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanismEur J Pharm Biopharm19984521491559704911
   PubMed Web of Science ®Google Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• WissingSAMüllerRHThe influence of solid lipid nanoparticles on skin hydration and viscoelasticity – in vivo studyEur J Pharm Biopharm2003561677212837483
   PubMed Web of Science ®Google Scholar
• JenningVGyslerASchäfer-KortingMGohlaSHVitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skinEur J Pharm Biopharm200049321121810799811
   PubMed Web of Science ®Google Scholar
• LvQYuAXiYDevelopment and evaluation of penciclovir-loaded solid lipid nanoparticles for topical deliveryInt J Pharm20093721–219119819429280
   PubMed Web of Science ®Google Scholar
• Schäfer-KortingMMehnertWKortingHCLipid nanoparticles for improved topical application of drugs for skin diseasesAdv Drug Delivery Rev2007596427443
   PubMed Web of Science ®Google Scholar
• MandawgadeSDPatravaleVBDevelopment of SLNs from natural lipids: application to topical delivery of tretinoinInt J Pharm20083631–213213818657601
   PubMed Web of Science ®Google Scholar
• CastroGACoelhoALLROliveiraCAMahechaGABOréficeRLFerreiraLAMFormation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticlesInt J Pharm20093811778319647057
   PubMed Web of Science ®Google Scholar
• SachdevaVSiddojuSYuYYKimHDFridenPMBangaAKTransdermal iontophoretic delivery of terbinafine hydrochloride: Quantitation of drug levels in stratum corneum and underlying skinInt J Pharm20103881–2243120025950
   PubMed Web of Science ®Google Scholar
• RepkaMAMididoddiPKStodghillSPInfluence of human nail etching for the assessment of topical onychomycosis therapiesInt J Pharm20042821–29510615336385
   PubMed Web of Science ®Google Scholar
• VakaSRKMurthySNO’HaverJHRepkaMAA platform for predicting and enhancing model drug delivery across the human nail plateDrug Dev Ind Pharm2011371727920545509
   PubMed Web of Science ®Google Scholar
• CevcGLipid vesicles and other colloids as drug carriers on the skinAdv Drug Delivery Rev2004565675711
   PubMed Web of Science ®Google Scholar
• WissingSAMüllerRHSolid lipid nanoparticles (SLN): a novel carrier for UV blockersPharmazie2001561078378611683123
   PubMed Web of Science ®Google Scholar